These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. [Systemic thrombolytic treatment in myocardial infarct]. Davi R; Copello F; Pareti G; Freggiaro V; Morelloni S; Corazza M; Fasciolo L; Allegri M Clin Ter; 1990 Aug 15-31; 134(3-4):223-35. PubMed ID: 2147625 [No Abstract] [Full Text] [Related]
12. [Pulmonary hemorrhage after thrombolysis in acute myocardial infarct]. Rodríguez Blanco VM; Barriales Alvarez V; Morís de la Tassa C An Med Interna; 1997 Apr; 14(4):209. PubMed ID: 9181820 [No Abstract] [Full Text] [Related]
14. Risk factors for intracranial hemorrhage and nonhemorrhagic stroke after fibrinolytic therapy (from the GUSTO-i trial). Kandzari DE; Granger CB; Simoons ML; White HD; Simes J; Mahaffey KW; Gore J; Weaver WD; Longstreth WT; Stebbins A; Lee KL; Califf RM; Topol EJ; Am J Cardiol; 2004 Feb; 93(4):458-61. PubMed ID: 14969623 [TBL] [Abstract][Full Text] [Related]
15. Thrombolytic therapy: Current status. Fratantoni JC; Ness P; Simon TL N Engl J Med; 1975 Nov; 293(21):1073-8. PubMed ID: 1178024 [No Abstract] [Full Text] [Related]
16. [The clinical aspects of using thrombolytic therapy in myocardial infarct at the prehospital stage]. Staroverov II; Dundua DP; Plotnikov AN; Pomerantsev EV; Bliumental' AA; Puchkov AT; Ovasapian IuA; Serov VP; Ruda MIa Kardiologiia; 1993; 33(3):28-32. PubMed ID: 8377336 [TBL] [Abstract][Full Text] [Related]
17. [Pulmonary hemorrhage and acute respiratory failure secondary to thrombolytic treatment with tissue plasminogen activator (rt-PA) in patients with acute myocardial infarction]. Sandar Núñez D; Ruiz Santana S; García Jiménez A; Castro Mao M Med Clin (Barc); 1997 Mar; 108(8):318. PubMed ID: 9121219 [No Abstract] [Full Text] [Related]
18. Stroke associated with thrombolytic therapy for acute myocardial infarction. Sloan MA Heart Dis Stroke; 1992; 1(5):287-94. PubMed ID: 1344119 [No Abstract] [Full Text] [Related]
19. [Myoglobin concentration in serum as an early marker of reperfusion in patients with acute myocardial infarction after thrombolytic therapy]. Kobusiak-Prokopowicz M; Mysiak A Pol Merkur Lekarski; 1997 Sep; 3(15):109-12. PubMed ID: 9461704 [TBL] [Abstract][Full Text] [Related]
20. Hemorrhagic ocular complications associated with the use of systemic thrombolytic agents. Chorich LJ; Derick RJ; Chambers RB; Cahill KV; Quartetti EJ; Fry JA; Bush CA Ophthalmology; 1998 Mar; 105(3):428-31. PubMed ID: 9499772 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]